These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 8549385
1. Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections. Niki Y, Tamada S, Nakabayashi M, Soejima R. Drugs; 1995; 49 Suppl 2():420-2. PubMed ID: 8549385 [No Abstract] [Full Text] [Related]
2. In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens. Yoshizumi S, Domon H, Miyazaki S, Yamaguchi K. Antimicrob Agents Chemother; 1998 Apr; 42(4):785-8. PubMed ID: 9559783 [Abstract] [Full Text] [Related]
7. In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens. Baquero F, Cantón R. J Antimicrob Chemother; 1996 May; 37 Suppl A():1-18. PubMed ID: 8737121 [Abstract] [Full Text] [Related]
8. Activity of grepafloxacin against respiratory isolates of Streptococcus pneumoniae. Johnson AP, Warner M, Parsons T. Eur J Clin Microbiol Infect Dis; 1997 Aug; 16(8):622-3. PubMed ID: 9323481 [No Abstract] [Full Text] [Related]
11. In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections. Miyazaki S, Domon H, Tateda K, Ohno A, Ishii Y, Matsumoto T, Furuya N, Yamaguchi K. Antimicrob Agents Chemother; 1997 Nov; 41(11):2582-5. PubMed ID: 9371375 [Abstract] [Full Text] [Related]
12. Antimicrobial activity of DW286 against Streptococcus pneumoniae. Park HS, Jung SJ, Choi DR, Kwak JH. Int J Antimicrob Agents; 2010 Sep; 36(3):230-3. PubMed ID: 20627463 [Abstract] [Full Text] [Related]
13. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae. Okamoto H, Miyazaki S, Tateda K, Ishii Y, Yamaguchi K. Antimicrob Agents Chemother; 2001 Nov; 45(11):3250-2. PubMed ID: 11600393 [Abstract] [Full Text] [Related]
14. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Fuller JD, Low DE. Clin Infect Dis; 2005 Jul 01; 41(1):118-21. PubMed ID: 15937772 [Abstract] [Full Text] [Related]
16. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae. Appelbaum PC. Clin Infect Dis; 2000 Aug 01; 31 Suppl 2():S29-34. PubMed ID: 10984325 [Abstract] [Full Text] [Related]
18. Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections. Goa KL, Bryson HM, Markham A. Drugs; 1997 Apr 01; 53(4):700-25. PubMed ID: 9098667 [Abstract] [Full Text] [Related]
19. Pharmacodynamics of a novel des-F(6)-quinolone, BMS-284756, against Streptococcus pneumoniae in the thigh infection model. Nicolau DP, Mattoes HM, Banevicius M, Xuan D, Nightingale CH. Antimicrob Agents Chemother; 2003 May 01; 47(5):1630-5. PubMed ID: 12709332 [Abstract] [Full Text] [Related]